| Combination of | |
|---|---|
| Glibenclamide | Sulfonylurea |
| Metformin | Biguanide |
| Clinical data | |
| Trade names | Glucovance |
| AHFS/ Drugs.com | Monograph |
| MedlinePlus | a699055 |
| License data | |
|
Pregnancy category |
|
|
Routes of administration | By mouth |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| KEGG | |
Glibenclamide/metformin, also known as glyburide/metformin and sold under the brand name Glucovance, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes. [6] It contains glibenclamide, a sulfonylureas, and metformin, a biguanide. [7]
References
- ^ a b "TGA eBS - Product and Consumer Medicine Information Licence". Archived from the original on 23 March 2022. Retrieved 30 April 2022.
- ^ "Search the TGA website".
- ^ "Search the TGA website".
- ^ "Search the TGA website". Archived from the original on 30 April 2022. Retrieved 30 April 2022.
- ^ "Glucovance- glyburide and metformin hydrochloride tablet, film coated". DailyMed. 23 April 2012. Archived from the original on 30 April 2022. Retrieved 30 April 2022.
- ^ Lamos EM, Stein SA, Davis SN (December 2012). "Combination of glibenclamide-metformin HCl for the treatment of type 2 diabetes mellitus". Expert Opinion on Pharmacotherapy. 13 (17): 2545–54. doi: 10.1517/14656566.2012.738196. PMID 23116560. S2CID 10305382.
- ^ "Glyburide and metformin hydrochloride tablet". DailyMed. 10 June 2020. Archived from the original on 26 February 2021. Retrieved 11 August 2020.
External links
- "Glyburide mixture with Metformin hydrochloride". Drug Information Portal. U.S. National Library of Medicine.
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |